Galectin-1 exerts inhibitory effects during DENV-1 infection

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Toledo, Karina Alves ^a   Fermino, Marise Lopes ^b   Del Cistia Andrade, Camillo ^b   Riul, Thalita Bachelli ^b   Alves, Renata Tomé ^b   Muller, Vanessa Danielle Menjon ^b   Russo, Raquel Rinaldi ^b   Stowell, Sean R ^c   Cummings, Richard D ^c   Aquino, Victor Hugo ^b   Dias Baruffi, Marcelo ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CARBOHYDRATE; GALECTIN 1; GALECTIN 3; LECTIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CELL TYPE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 1; DIMERIZATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; INTERNALIZATION; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA VIRUS; VIRUS ATTACHMENT; ADSORPTION; ANIMAL; C57BL MOUSE; CELL DEATH; CELL LINE; CELL LINEAGE; CELL SURVIVAL; CHEMISTRY; CLASSIFICATION; CYTOLOGY; DENGUE VIRUS; FLOW CYTOMETRY; METABOLISM; TRANSGENIC MOUSE;

ADSORPTION; ANIMALS; ANTIVIRAL AGENTS; CARBOHYDRATES; CELL DEATH; CELL LINE; CELL LINEAGE; CELL SURVIVAL; DENGUE; DENGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GALECTIN 1; GALECTIN 3; HUMANS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECOMBINANT PROTEINS;

EID: 84911926248     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112474     Document Type: Article

References (65)

1. Murray NE, Quam MB, Wilder-Smith A (2013) Epidemiology of dengue: past, present and future prospects. Clin Epidemiol 5: 299-309.
2. Beaumier CM, Gillespie PM, Hotez PJ, Bottazzi ME (2013) New vaccines for neglected parasitic diseases and dengue. Transl Res 162: 144-155.
3. Guzman MG, Kouri G (2002) Dengue: an update. Lancet Infect Dis 2: 33-42.
4. Halstead SB (2002) Dengue hemorrhagic fever: two infections and antibody dependent enhancement, a brief history and personal memoir. Rev Cubana Med Trop 54: 171-179.
5. Whitehorn J, Yacoub S, Anders KL, Macareo LR, Cassetti MC, et al. (2014) Dengue Therapeutics, Chemoprophylaxis, and Allied Tools: State of the Art and Future Directions. PLoS Negl Trop Dis 8: e3025.
6. NaTHNaC (2009) Dengue Fever. Health Protection Agency. Natural Travel Health Network and Centre.
7. Hughes RC (1997) The galectin family of mammalian carbohydrate-binding molecules. Biochem Soc Trans 25: 1194-1198.
8. Camby I, Le Mercier M, Lefranc F, Kiss R (2006) Galectin-1: a small protein with major functions. Glycobiology 16: 137R-157R.
9. Thijssen VL, Griffioen AW (2014) Galectin-1 and-9 in angiogenesis: A sweet couple. Glycobiology 24: 915-920.
10. Stowell SR, Cho M, Feasley CL, Arthur CM, Song X, et al. (2009) Ligand reduces galectin-1 sensitivity to oxidative inactivation by enhancing dimer formation. J Biol Chem 284: 4989-4999.
11. Barondes SH, Cooper DN, Gitt MA, Leffler H (1994) Galectins. Structure and function of a large family of animal lectins. J Biol Chem 269: 20807-20810.
12. Sato S, Ouellet M, St-Pierre C, Tremblay MJ (2012) Glycans, galectins, and HIV-1 infection. Ann N Y Acad Sci 1253: 133-148.
13. Stowell SR, Arthur CM, Dias-Baruffi M, Rodrigues LC, Gourdine JP, et al. (2010) Innate immune lectins kill bacteria expressing blood group antigen. Nat Med 16: 295-301.
14. Stowell SR, Arthur CM, McBride R, Berger O, Razi N, et al. (2014) Microbial glycan microarrays define key features of host-microbial interactions. Nat Chem Biol 10: 470-476.
15. Arthur CM, Cummings RD, Stowell SR (2014) Using glycan microarrays to understand immunity. Curr Opin Chem Biol 18: 55-61.
16. Cedeno-Laurent F, Dimitroff CJ (2012) Galectin-1 research in T cell immunity: past, present and future. Clin Immunol 142: 107-116.
17. Levroney EL, Aguilar HC, Fulcher JA, Kohatsu L, Pace KE, et al. (2005) Novel innate immune functions for galectin-1: galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines. J Immunol 175: 413-420.
18. Garner OB, Aguilar HC, Fulcher JA, Levroney EL, Harrison R, et al. (2010) Endothelial galectin-1 binds to specific glycans on nipah virus fusion protein and inhibits maturation, mobility, and function to block syncytia formation. PLoS Pathog 6: e1000993.
19. Poisa-Beiro L, Dios S, Ahmed H, Vasta GR, Martínez-López A, et al. (2009) Nodavirus infection of sea bass (Dicentrarchus labrax) induces up-regulation of galectin-1 expression with potential anti-inflammatory activity. J Immunol 183: 6600-6611.
20. Yang ML, Chen YH, Wang SW, Huang YJ, Leu CH, et al. (2011) Galectin-1 binds to influenza virus and ameliorates influenza virus pathogenesis. J Virol 85: 10010-10020.
21. Rajasagi NK, Suryawanshi A, Sehrawat S, Reddy PB, Mulik S, et al. (2012) Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions. J Immunol 188: 4631-4643.
22. Ouellet M, Mercier S, Pelletier I, Bounou S, Roy J, et al. (2005) Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells. J Immunol 174: 4120-4126.
23. Mercier S (2008) Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption. Virology 371: 121-129.
24. St-Pierre C, Manya H, Ouellet M, Clark GF, Endo T, et al. (2011) Host Soluble Galectin-1 Promotes HIV-1 Replication through a Direct Interaction with Glycans of Viral gp120 and Host CD4. J Virol 85: 11742-11751.
25. St-Pierre C, Ouellet M, Giguère D, Ohtake R, Roy R, et al. (2012) Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection. Antimicrob Agents Chemother 56: 154-162.
26. Reynolds JL, Law WC, Mahajan SD, Aalinkeel R, Nair B, et al. (2012a) Morphine and galectin-1 modulate HIV-1 infection of human monocyte-derived macrophages. J Immunol 188: 3757-3765.
27. Reynolds JL, Law WC, Mahajan SD, Aalinkeel R, Nair B, et al. (2012b) Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophages. J Neuroim-mune Pharmacol 7: 673-685.
28. Gonzalez MI, Rubinstein N, Ilarregui JM, Toscano MA, Sanjuan NA, et al. (2005) Regulated expression of galectin-1 after in vitro productive infection with herpes simplex virus type 1: implications for T cell apoptosis. Int J Immuno-pathol Pharmacol 18: 615-623.
29. Gauthier S, Pelletier I, Ouellet M, Vargas A, Tremblay MJ, et al. (2008) Induction of galectin-1 expression by HTLV-I Tax and its impact on HTLV-I infectivity. Retrovirology 5: 105.
30. 2 from Crotalus durissus terrificus showed antiviral activity against dengue and yellow fever viruses. Toxicon 59: 507-515.
31. Gualano RC, Pryor MJ, Cauchi MR, Wright PJ, Davidson AD (1998) Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomic-length cDNA. J Gen Virol 79: 437-446.
32. Ip PP, Liao F (2010) Resistance to dengue virus infection in mice is potentiated by CXCL10 and is independent of CXCL10-mediated leukocyte recruitment. J Immunol 184.: 5705-5714.
33. Stowell SR, Qian Y, Karmakar S, Koyama NS, Dias-Baruffi M, et al. (2008) Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion. J Immunol 180: 3091-3102.
34. Stowell SR, Karmakar S, Arthur CM, Ju T, Rodrigues LC, et al. (2009) Galectin-1 induces reversible phosphatidylserine exposure at the plasma membrane. Mol Biol Cell 20: 1408-1418.
35. Cho M, Cummings RD (1995) Galectin-1, a beta-galactoside-binding lectin in Chinese hamster ovary cells. I. Physical and chemical characterization. J Biol Chem 270: 5198-5206.
36. Cho M, Cummings RD (1996) Characterization of monomeric forms of galectin-1 generated by site-directed mutagenesis. Biochemistry 35: 13081-13088.
37. Koishi AC, Zanello PR, Bianco EM, Bordignon J, Nunes Duarte dos Santos C (2012) Screening of Dengue virus antiviral activity of marine seaweeds by an in situ enzyme-linked immunosorbent assay. PLoS One 7: e51089.
38. dos Santos HW, Poloni TR, Souza KP, Muller VD, Tremeschin F, et al. (2008) A simple one-step real-time RT-PCR for diagnosis of dengue virus infection. J Med Virol 80: 1426-1433.
39. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
40. Lee JY, Kim JY, Lee YG, Byeon SE, Kim BH, et al. (2007) In vitro immunoregulatory effects of Korean mistletoe lectin on functional activation of monocytic and macrophage-like cells. Biol Pharm Bull 30: 2043-2051.
41. Agis-Juárez RA, Galván I, Medina F, Daikoku T, Padmanabhan R, et al. (2009) Polypyrimidine tract-binding protein is relocated to the cytoplasm and is required during dengue virus infection in Vero cells. J Gen Virol 90: 2893-2901.
42. Mosso C, Galván-Mendoza IJ, Ludert JE, del Angel RM (2008) Endocytic pathway followed by dengue virus to infect the mosquito cell line C6/36 HT. Virology 378: 193-199.
43. Warke RV, Xhaja K, Martin KJ, Fournier MF, Shaw SK, et al. (2003) Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol 77: 11822-11832.
44. Warke RV, Becerra A, Zawadzka A, Schmidt DJ, Martin KJ, et al. (2008) Efficient dengue virus (DENV) infection of human muscle satellite cells upregulates type I interferon response genes and differentially modulates MHC I expression on bystander and DENV-infected cells. J Gen Virol 89: 1605-1615.
45. Vervaeke P, Alen M, Noppen S, Schols D, Oreste P, et al. (2013) Sulfated Escherichia coli K5 Polysaccharide Derivatives Inhibit Dengue Virus Infection of Human Microvascular Endothelial Cells by Interacting with the Viral Envelope Protein E Domain III. PLoS ONE 8(8): e74035.
46. Kyle JL, Beatty PR, Harris E (2007) Dengue virus infects macrophages and dendritic cells in a mouse model of infection. J Infect Dis 195: 1808-1817.
47. Prestwood TR, May MM, Plummer EM, Morar MM, Yauch LE, et al. (2012) Trafficking and replication patterns reveal splenic macrophages as major targets of dengue virus in mice. J Virol 86: 12138-12147.
48. Mairiang D, Zhang H, Sodja A, Murali T, Suriyaphol P, et al. (2013) Identification of new protein interactions between dengue fever virus and its hosts, human and mosquito. PLoS One 8: e53535.
49. Rodenhuis-Zybert IA, Wilschut J, Smit JM (2010) Dengue virus life cycle: viral and host factors modulating infectivity. Cell Mol Life Sci 67: 2773-2786.
50. Demetriou M, Granovsky M, Quaggin S, Dennis JW (2001) Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409: 733-739.
51. Nieminen J, Kuno A, Hirabayashi J, Sato S (2007) Visualization of galectin-3 oligomerization on the surface of neutrophils and endothelial cells using fluorescence resonance energy transfer. J Biol Chem 282: 1374-1383.
52. Brewer CF, Miceli MC, Baum LG (2002) Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr Opin Struct Biol 12: 616-623.
53. Lim JW, Kim H, Kim KH (2003) Cell adhesion-related gene expression by Helicobacter pylori in gastric epithelial AGS cells. Int J Biochem Cell Biol 35: 1284-1296.
54. Sato S, St-Pierre C, Bhaumik P, Nieminen J (2009) Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunol Rev 230: 172-187.
55. Vasta GR (2009) Roles of galectins in infection. Nat Rev Microbiol 7: 424-438.
56. Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A (2003) Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci USA 100: 14333-14338.
57. Kyle JL, Beatty PR, Harris E (2007) Dengue virus infects macrophages and dendritic cells in a mouse model of infection. J Infect Dis 195: 1808-1817.
58. Moreno-Altamirano MM, Sánchez-García FJ, Legorreta-Herrera M, Aguilar-Carmona I (2007) Susceptibility of mouse macrophage J774 to dengue virus infection. Intervirology 50: 237-239.
59. Wahala WM, Silva AM (2011) The human antibody response to dengue virus infection. Viruses 3: 2374-2395.
60. Salatino M, Croci DO, Bianco GA, Ilarregui JM, Toscano MA, et al. (2008) Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer. Expert Opin Biol Ther 8: 45-57.
61. Acosta EG, Castilla V, Damonte EB (2009) Alternative infectious entry pathways for dengue virus serotypes into mammalian cells. Cell Microbiol 11: 1533-1549.
62. Horie H, Kadoya T, Sango K, Hasegawa M (2005) Oxidized galectin-1 is an essential factor for peripheral nerve regeneration. Curr Drug Targets 6: 385-394.
63. Kami K, Senba E (2005) Galectin-1 is a novel factor that regulates myotube growth in regenerating skeletal muscles. Curr Drug Targets 6: 395-405.
64. Kato T, Ren CH, Wada M, Kawanami T (2005) Galectin-1 as a potential therapeutic agent for amyotrophic lateral sclerosis. Curr Drug Targets 6: 407-418.
65. Zúñiga E, Gruppi A, Hirabayashi J, Kasai KI, Rabinovich GA, et al. (2001) Regulated expression and effect of galectin-1 on Trypanosoma cruzi-infected macrophages: modulation of microbicidal activity and survival. Infect Immun 69: 6804-6812